Ozone exposure, vitamin C intake, and genetic susceptibility of asthmatic children in Mexico City: a cohort study
- Hortensia Moreno-Macías1_1319Email author,
- Douglas W Dockery2_1319,
- Joel Schwartz2_1319,
- Diane R Gold2_1319,
- Nan M Laird3_1319,
- Juan J Sienra-Monge4_1319,
- Blanca E Del Río-Navarro4_1319,
- Matiana Ramírez-Aguilar5_1319,
- Albino Barraza-Villarreal6_1319,
- Huiling Li7_1319,
- Stephanie J London7_1319Email author and
- Isabelle Romieu8_1319Email author
© Moreno-Macías et al.; licensee BioMed Central Ltd. 2013
Received: 26 September 2012
Accepted: 24 January 2013
Published: 4 February 2013
We previously reported that asthmatic children with GSTM1 null genotype may be more susceptible to the acute effect of ozone on the small airways and might benefit from antioxidant supplementation. This study aims to assess the acute effect of ozone on lung function (FEF25-75) in asthmatic children according to dietary intake of vitamin C and the number of putative risk alleles in three antioxidant genes: GSTM1, GSTP1 (rs1695), and NQO1 (rs1800566).
257 asthmatic children from two cohort studies conducted in Mexico City were included. Stratified linear mixed models with random intercepts and random slopes on ozone were used. Potential confounding by ethnicity was assessed. Analyses were conducted under single gene and genotype score approaches.
The change in FEF25-75 per interquartile range (60 ppb) of ozone in persistent asthmatic children with low vitamin C intake and GSTM1 null was −91.2 ml/s (p = 0.06). Persistent asthmatic children with 4 to 6 risk alleles and low vitamin C intake showed an average decrement in FEF25-75 of 97.2 ml/s per 60 ppb of ozone (p = 0.03). In contrast in children with 1 to 3 risk alleles, acute effects of ozone on FEF25-75 did not differ by vitamin C intake.
Our results provide further evidence that asthmatic children predicted to have compromised antioxidant defense by virtue of genetic susceptibility combined with deficient antioxidant intake may be at increased risk of adverse effects of ozone on pulmonary function.
KeywordsAir pollution Asthmatic children Antioxidant genes Mexico City Vitamin C
Ozone is a potent oxidant that easily reaches the lung lining fluid compartment  providing an additionala source of reactive oxygen species and causing, among other outcomes, reversible declines in lung function . Vitamin C is an exogenous nonenzymatic antioxidant that participates in the primary lung defense against reactive oxygen species . Several epidemiological studies have suggested that a diet rich in antioxidants may lessen the effect of ozone on respiratory health of susceptible populations [4, 5].
With respect to genetics, epidemiological studies have shown that the effect of ozone on the respiratory health of asthmatic children may be modulated by the functional genetic polymorphisms of antioxidant genes such as Glutathione S transferase (GST) M1, (GST)P1, and NQO1[6, 7]. These genes code for phase II xenobiotic detoxifying enzymes that participate in the intracellular defense against oxidative stress. They are members of the Nrf2 pathway, responsible for the expression of enzymes that conjugate and inactivate reactive oxygen species .
In a randomized controlled trial of antioxidant supplementation (vitamin C and E) among asthmatic children in Mexico City, we reported that children in the placebo group with GSTM1 null genotype may be more vulnerable to the adverse effects of ozone on lung function than those who were taking antioxidant supplementation and those with GSTM1 positive genotype, regardless of the treatment group . In the previous analysis, GSTM1 was classified as null versus positive. In the current analysis, the number of copies of GSTM1 (0, 1 or 2) was quantified; and we examined whether dietary intake of vitamin C in combination with common functional variants in three antioxidant genes (GSTM1, GSTP1 and NQO1) influences the relationship between ozone exposure and lung function (FEF25-75) in Mexican asthmatic children exposed to high ozone levels. In addition to examining the functional polymorphisms in these three antioxidant genes separately, we created a putative antioxidant deficiency genetic risk score by combining genotypes across them.
Methods and materials
See Additional file 1 for further explanation of the methods mentioned below.
Asthma status and severity were confirmed by a pediatric allergist using Global Initiative for Asthma (GINA) guidelines . Severity was rated as intermittent or persistent (mild, moderate, or severe). Ozone exposure (1-h maximum) and daily temperature were characterized from the measurements at the monitoring station closest to each child’s home.
In the “Antioxidants” cohort, at baseline, children were randomly assigned (double-blind) to receive either placebo or supplement (vitamins C and E). EVA was an observational study; thus, there was no controlled supplementation.
Individual dietary intake was assessed using a version of the validated food frequency questionnaire developed by Willett  adapted to the Mexican population. Vitamin C intake was adjusted for total caloric intake . Intake was increased by 250 mg/day for children assigned to the supplementation group or by the reported intake for those taking supplements.
Genotyping was performed for the GSTM1, GSTP1 (rs1695), and NQO1 (rs1800566) polymorphisms, using polymerase chain reaction-based methods. 257 children were genotyped for GSTM1 and GSTP1; a subset of 199 children was also genotyped for NQO1, having participated in a parallel study of nuclear families . In 160 of the asthmatic children with additional genotype data available, individual ancestry proportions were estimated using the program FRAPPE  based on three ancestral populations: Native-American, European, and African .
Since children from the EVA cohort did not receive antioxidant supplementation, they were considered similar to children taking placebo in the Antioxidant cohort. We verified that these two groups did not differ in genotype frequencies. Vitamin C intake was dichotomized in this combined group using the median intake (105 mg/d). Children receiving supplementation, as part of the “Antioxidant” study, were classified into a higher intake group which had more than 280 mg/d. Thus, according to the distribution of vitamin C intake, we had three levels: (30–105), (>105-226), and (280-477 mg/day), hereafter referred to as “low”, “medium”, and “high” vitamin C, respectively.
We first analyzed the relationship between ozone exposure and FEF25-75 separately for each genotype of the three genes separately. Given that the relationships between the outcome and the concentrations of ozone in children with 1 or 2 GSTM1 copies were similar each other but different to the observed in children with 0 copies (null genotype), we collapsed GSTM1 into null and positive. A similar situation was observed for GSTP1 and NQO1 genotypes. Thus, we defined “at genetic risk” (GR) and “not at genetic risk” (NGR) groups as follows: GSTM1 null versus positive; GSTP1 Val/Val versus Ile/Val + Ile/Ile, and NQO1 Pro/Pro versus Pro/Ser + Ser/Ser.
After combining genotype and vitamin C intake, six strata were formed: (GR-low diet), (GR-medium), (GR-high), (NGR-low), (NGR-medium), and, (NGR-high) for each gene.
Subsequently, genes were grouped to create a putative antioxidant susceptibility genetic risk score by counting the number of risk alleles. Genotype score analysis included only children with complete genotype for all genotypes (n = 199). The creation of this index is detailed in Additional file 1: Table S1. We first explored the relationship between the outcome and ozone exposure within four genetic risk score groups collapsed because of sample size: 1 or 2 risk alleles; 3; 4; and 5 or 6. Since we observed that children with 3 risk alleles had similar response to the 1–2 risk alleles group and children with 4 risk alleles had similar response to children in the 5–6 risk allele group, we formed only two groups: 1 to 3, and 4 to 6 risk alleles. Additionally, given that no significant effect of ozone on FEF25-75 was observed in children with “medium” or “high” vitamin C groups, they were combined in a single “high” level for greater stability of estimates.
Thus, from the combination between the two susceptibility categories (1 to 3 or 4 to 6 risk alleles) and the two levels of vitamin C intake (low-high), four strata were formed: (1 to 3-low), (1 to 3-high), (4 to 6-low), and (4 to 6-high).
We analyzed all asthmatic children together and also grouped children with mild-persistent, moderate-persistent, and severe-persistent asthma into a “persistent” asthmatic group, which was analyzed separately.
To investigate whether vitamin C intake plus genotype modulates the relationship between ozone exposure and lung function, stratified linear mixed models with random intercept and random slope on ozone were fit in the whole sample and into the “persistent” group alone as well.
The stratified models were adjusted for age, gender, body mass index, height, time, cohort (Antioxidants or EVA), use of bronchodilator, and previous day minimum temperature. Previous day’s 1-h maximum ozone was the exposure. Effect estimates were calculated per interquartile range (IQR), which was 60 ppb. Genotype effect was calculated as the difference in coefficients for FEF25-75 in relation to ozone by genotype group. Diet effect was calculated as the difference between these coefficients between vitamin C groups.
Potential confounding by admixture was examined using exclusively the subsample of 160 children with ethnicity information. The association between each polymorphism and FEF25-75 was assessed through two linear mixed models. The first model was adjusted for age, gender, body mass index, height, time, cohort, use of bronchodilator, and previous day minimum temperature. The second model was also adjusted for Native-American ancestry but ancestry was not associated with the outcome and thus was not a confounder and was not retained in final models. Analysis was conducted using R software (version 2.9.1; the R foundation for Statistical Computing).
Characteristics of the study population of 257 asthmatic children residing in Mexico City 1998-2004
% or median(IQR)*
Antioxidant Study participants (%)
Vitamin C intake
Supplementation group (%)
Vitamin C intake in supplementation group (mg/d)
Vitamin C intake out of supplementation group (mg/d)
Moderate- and severe-persistent asthma (%)
Mild-persistent asthma (%)
Mild-intermittent asthma (%)
Genotype and allele frequency
GSTM1 (Number of copies) †
Ile/Ile + Ile/Val
NQO1 rs1800566 ‡
Pro/Ser + Ser/Ser
Ethnicity (%) §
The 1-h maximum ranged from 10 to 309 ppb with a mean of 96.9 ppb. The Mexican standard (110 ppb 1 h maximum) was exceeded on 30.7% of the days. (Additional file 1: Table S3).
Ozone effects by genotype group –All asthmatics
We found no overall effect of ozone on FEF25-75 (−3.3 ml/s; p = 0.76). In analyses by genotype, asthmatic children with the GSTM1 null genotype appeared to experience a stronger ozone effect on lung function (−25.8 ml/s; p = 0.13; n = 93) than children with one (3.9 ml/s; p = 0.80; n = 129) or two (22.2 ml/s: p = 0.48; n = 35) copies. These results suggest a positive linear trend between the number of GSTM1 copies and the average change in FEF25-75 in response to ozone exposure (p-trend = 0.09). We did not identify a potential susceptible group by GSTP1 genotypes. (Additional file 1: Table S4).
Ozone effects by genotype group -persistent asthmatics
We found no overall effect of ozone on FEF25-75 (−16.2 ml/s; p = 0.55). Children with no GSTM1 copy appeared to have stronger ozone-induced FEF25-75 decrements (−36.6 ml/s; p = 0.05; n = 65) than children with one (−15.0 ml/s; p = 0.42; n = 81) or two copies (23.7 ml/s; p = 0.59; n = 18) (p-trend = 0.10). We did not identify a potential susceptible group by GSTP1 or NQO1 genotypes (Additional file 1: Table S4).
Vitamin C intake
Recommended Daily Intake (RDI, 45 mg/day) by gender and age was exceeded for all but one child.
Ozone effects by Vitamin C -All asthmatics
No significant effect of ozone was observed through the different levels of vitamin C intake.
Ozone effects by vitamin C -persistent asthmatics
Children in the lowest vitamin C intake group (≤ 105 mg/day) and with “persistent” asthma had average decrement in FEF25-75 per 60 ppb ozone of −61.2 ml/s (p = 0.02). No significant effect of ozone was observed with higher vitamin C intake (Additional file 1: Table S5).
Effect of ozone on FEF25-75 stratified by genotype for each of the three antioxidant genes and vitamin C intake
Ozone effects by genotype and vitamin C -All asthmatics
Effect of ozone on FEF 25-75 , according to genotype and vitamin C intake &
Vitamin C intake
−69.0 (−144.0, 6.0)£
−16.2 (−66.8, 34.4)
−13.8 (−58.5, 30.9)
−12.6 (−57.3, 32.1)
22.2 (−23.7, 68.1)
6.9 (−38.9, 52.8)
Genotype effect Ω
56.4 (−138.0, 27.0)
20.7 (−43.2, 84.6) *
−91.2 (−184.1, 1.7)£
−23.4 (−81.0, 34.2)
−13.2 (−77.9, 51.5)
−35.4 (−102.4, 31.6)
−15.6 (−69.7, 38.4)
13.8 (−40.3, 67.9) **
55.8 (56.4, -168.0)
7.8 (−114.0, 84.0)
27.0 (−57.6, 111.6)
−43.2 (−106.7, 20.3)
2.4 (−56.4, 61.2)
3.6 (−65.8, 73.0)
Ile/Val + Ile/Ile
−24.0 (−74.6, 26.6)
7.8 (−32.2, 47.8)
3.6 (−35.2, 42.4)
19.2 (−68.4, 106.8)
5.4 (−65.4, 76.2)
0.0 (−79.8, 79.8)
−82.8 (−167.5, 1.9)£
−33.0 (−104.7, 38.7)
18.2 (−67.8, 103.8) *
Ile/Val + Ile/Ile
−54.0 (−119.9, 11.9)
−12.0 (−59.0, 35.0)
0.0 (−49.4, 49.4)
28.8 (−96.6, 154.2)
21.0 (−64.8, 106.8)
−18.2 (−117.0, 81.0)
−55.2 (−134.0, 23.6)
50.4 (−17.8, 118.6)
−37.8 (−114.2, 38.6)
Pro/Ser + Ser/Ser
−4.8 (−62.4, 52.8)
−10.8 (−56.7, 35.1)
10.8 (−29.2, 50.8)
50.4 (−45.4, -144.0)
−75.0 (−182.0, 32.0)
−0.3 (−69.7, 69.1)
−39.6 (−119.6, 40.4)
Pro/Ser + Ser/Ser
−42.0 (−105.5, 21.5)
−17.4 (−70.3, 35.5)
17.4 (−32.0, 69.0) **
Ozone effects by genotype and vitamin C -persistent asthmatics
Effect of ozone on FEF25-75 by genotype score and vitamin C intake
Only 7 children (3.5%) had all 6 risk alleles (no GSTM1 copies, Val/Val, and Pro/Pro genotypes) and 48.3% had 4 or more risk alleles (Additional file 1: Table S1).
Ozone effects by genotype score and vitamin C -All asthmatics
Effect of ozone on FEF 25-75 , according to the number of risk alleles and vitamin C &
1 to 3
24.0 (−50.0, 98.1)
27.0 (−16.5, 70.5)
3.0 (−82.2, 88.2)
4 to 6
−58.8 (−122.3, 0.1) £
−16.8 (−49.7, 16.1)
Genotype effect Ω
−82.8 (−180.0, 15.0) £
−43.8 (−98.4, 11.4)
1 to 3
19.2 (−67.8, 106.2)
15.6 (−35.0, 66.2)
−3.6 (−105.6, 98.4)
4 to 6
−97.2 (−185.4, -9.0) €
−18.6 (−58.6, 21.4)
78.6 (77.1, 80.1) £
−116.4 (−118.4, -114.4) £
−34.2 (−98.4, 30.0)
Ozone effects by genotype score and vitamin C -persistent asthmatics
Looking at the low vitamin C intake group, the difference between the average decrements of children with 1 to 3 risk alleles against children with 4 to 6 was −116.4 ml/s (p = 0.08). Looking at the group with 4 to 6 risk alleles, the difference between the average decrements of children with low against high vitamin C intake, was 78.6 ml/s (p = 0.07) Table 3.
We found suggestive evidence that the acute effects of ozone exposure on asthmatic children’s pulmonary function may depend on both antioxidant genes and dietary intake of vitamin C. These ozone effects appear more pronounced in persistent asthmatic children. In addition, the cumulative effect of genetic susceptibility in GSTM1, GSTP1, and NQO1 polymorphisms and low intake of vitamin C was associated with the largest decrement in FEF25-75 among children with persistent asthma.
GSTM1 has been most intensively studied as a deleted versus a nondeleted dichotomous polymorphism; there are few data using GSTM1 copy number. In this study, we found a potential dose–response effect of GSTM1 on the relationship between FEF25-75 and ozone exposure. This result is consistent with the dose–response relationship between GSTM1 and the risk of lung cancer on smokers .
In human lung cells, GSTP1 Val/Val genotype has been associated with reduced GST Pi enzymatic activity . Our finding that the Val/Val may confer higher susceptibility to ozone damage than Ile/Val or Ile/Ile genotypes is consistent with that result. In addition, some epidemiologic studies have reported associations between Val/Val genotype and reduced lung function in young adults  and increased risk of early onset of asthma [25, 26]. Discrepancies with other studies [27, 28] that report the Val allele as protective may be related to ethnic differences among populations, with their consequent differences in linkage disequilibrium patterns, or due to change variation among studies.
Regarding diet, persistent asthmatics with low daily vitamin C intake had significant decrements in FEF25–75 associated to ozone exposure, but the effect of ozone was lessened among children with vitamin C intake over 105 mg/day. Our results suggest that persistent asthmatic children exposed to ozone might benefit from vitamin C intake above the RDI. Intake of > 105 mg/day was reached in our study from diet alone. This suggests that children do not need to take supplements. Consumption of daily fruits and vegetables may provide enough vitamin C for lessening the effects of ozone, on lung function, regardless the combination of antioxidant genotypes. Furthermore, fruits and vegetables provide additional nutrients that supplements do not include.
When genetic and dietary data were combined, persistent asthmatics with both low vitamin C intake and GSTM1 null or Val/Val GSTP1 had, on average, lower levels of FEF25–75 than other children.
Although our selection of 105 mg/day as the cutoff was based on the data distribution, it is according with the increment of 100 mg/d suggested by some studies for increasing about 10-50 ml in FEV1.
Using our genotype score as an index of genetic susceptibility, we found that the effect of ozone on persistent asthmatics with less than 105 mg/day vitamin C and with 4 to 6 risk alleles was slightly stronger than that estimated for GSTM1 under the single gene approach in the same dietary group (−97.2 ml/s against −91.2 ml/s respectively). The difference between both effects was not significant (p = 0.88). This result suggests that the GSTM1 genotype alone could have been used as an indicator of susceptibility to ozone.
As a result of environmental health policies in Mexico City, concentrations of ozone have been reduced over time. From 1998 to 2000 (first cohort enrollment), the average concentrations were between 100 and 125 ppb; while by the second cohort enrollment (2003–2005), concentrations were between 85 to 100 ppb . When we fit separated models by cohort, we found that in the first cohort, the effect of ozone on children with low vitamin C intake and GSTM1 null genotype, was −96.0; 95% CI(−204.0,12.6); whereas a lower effect was observed in the second cohort (−20.4; 95% CI (−114.6, 73.2)). Thus, final models were adjusted for a covariate accounting for the cohort.
Although our focus was on FEF25-75, we also analyzed the association between ozone and other measures of lung function including FEV1, FVC and PEF but we did not find any significant effect.
Regarding to the assessment of the potential confounding role of ethnicity, we rejected the null hypothesis of association between Native-American ancestry and the outcome setting an alpha-level of 0.20 instead of 0.05 level in order to insure adequate power to detect any important confounder effect . This lack of confounder effect may be explained by the fact that the children were recruited at the same Public Hospital suggesting similar socioeconomic status.
Some advantages and limitations of our study need to be addressed. Advantages include repeated measurements of FEF25-75. Obtaining longitudinal measurements of quantitative phenotypes reduces potential outcome misclassification and increases power by focusing on within-subject variations in outcome while controlling for among subjects differences using random intercepts and random slopes on time-dependent ozone exposure.
We were able to assess the potential confounding effect of population admixture and thereby exclude any potential confounding effect of admixture from our data. This is the first time that the confounding role of ethnicity in the association between genotype and respiratory health of Mexican asthmatic children exposed to ozone has been assessed. Ethnicity was based on genome-wide association genotyping. The absence of association between the levels of FEF25-75 and ethnicity in these Mexican asthmatic children supports the validity of previously-reported genetic associations in this population [9, 32].
Potential limitations include inaccuracy in assessment of personal ozone exposure. Because exposure assessment was based on monitoring stations located within 5 km from the children’s homes, potential misclassification of exposure is possible. However, using personal monitors on a subset of participants in the “Antioxidants” study (n = 144), a significant association (p < 0.01) between personal and ambient ozone levels was observed . Based on this validation, we would expect any misclassification in exposure to be random with the consequence of underestimating the adverse effect of ozone.
We were not able to measure plasma vitamin C levels of the participants but a validated food frequency questionnaire was used to estimate intake. Self-reported vitamin C intake was adjusted for total caloric intake. Through this adjustment, the between-person variation due to over- or under reporting of intake is reduced and a gain in accuracy is potentially obtained [18, 34]. Under this assumption, we would expect any misclassification in vitamin C intake to be random; therefore its potential protective effect may be underestimated.
While we focused on dietary vitamin C intake, we recognize that vitamin E has also been positively related to lung function. Children in the highest level of vitamin C intake had 50 mg per day of vitamin E as part of the antioxidant supplementation. It is worthy to note that although children in the medium level of vitamin C did not have supplementation, they had no significant ozone effects. Therefore, the effect of vitamin C might be predominant. Nevertheless, since both vitamin C and E may be present in the same foods, and because the biological interplay between them , part of the effect observed for vitamin C may be related to vitamin E intake as well.
Although ozone has received a great deal of attention, PM2.5 has also been associated with respiratory diseases. However, since concentrations of PM2.5 in México City only began to be registered by the network in 2000, we were not able to analyze the effect of this pollutant. Nevertheless, when data were available, it has been observed that PM2.5 and ozone are correlated (r = 0.46; p < 0.0001) . Thus, part of the effect observed for ozone may be related to PM2.5 exposure.
Selection bias is unlikely because those children without diet or genotype information were not aware of their individual susceptibility to ozone exposure. In addition, included and excluded groups had similar characteristics. Moreover, we used an objective measure of ozone effect – pulmonary function.
We acknowledge that our sample size was relatively small. Large sample sizes are required to study multi-way interactions with complex diseases such as asthma. In contrast, longitudinal studies of quantitative traits with repeated measurements are more powerful than cross-sectional studies of binary disease outcomes. Thus, despite our modest sample size, we were able to examine effects of ozone and diet on repeated measures analyses of the quantitative traits of FEF25-75 in our asthmatic children.
Although we are not aware of a study with similar design that could be used for replication, a number of observational studies suggest that vitamin C may reduce asthma risk and may prevent inflammatory response in the airways by reducing reactive oxygen species . Further, the intake of vitamin C and of fruits rich in vitamin C has been positively associated to lung function . Moreover, the protective effect of high fruits and vegetables intake has been reported as having potentially inverse modifying influence to cigarette smoking on the asthma risk for genetically vulnerable individuals  and the antioxidant role of some genes such as GSTM1, GSTP1, and NQO1 has been recognized [6, 7, 26].
Albeit reported p-values throughout this paper have not been corrected for multiple comparisons, we believe that it is unlikely to detect effects due to statistical fluctuations only because of the epidemiological evidence for the interactive effects of air pollutants with vitamin C intake [29, 35, 38] and antioxidant genes [25, 27, 28] on asthma symptoms and lung function.
We conclude that dietary vitamin C intake, either from fruits and vegetables or supplementation provides some protection against the effect of ozone on the pulmonary function of asthmatic children in an area with high ozone exposures– Mexico City. Effects of ozone were predominantly seen in the lowest tertile of vitamin C intake – up to 105 mg/day. Daily consumption of a slice of papaya or pineapple and 2 oranges, for example, can provide more than 105 mg/day of vitamin C. Dietary modification to increase intake of fruits rich in vitamin C is a simple intervention that is likely to have other health benefits. Ozone may have a greater impact on the respiratory health of children with deficient enzymatic activity on antioxidant genes and with low vitamin C intake than on that of children who have adequate enzymatic activity, vitamin C intake, or both.
a Normal metabolic processes in all cells are the main endogenous sources of reactive oxygen species.
b “Emission vehicular and asthma” in Spanish.
Glutathione S-tranferase M1
Glutathione S-tranferase P1
Nicotinamide adenine dinucleotide (phosphate) reduced: Quinone Oxidoreductase
- FEF25-75 :
Forced Expiratory Flow between 25 and 75 s
Emission vehicular and asthma.
The authors thank the children who took part in the study and Irma Lara who carried out the field work. This work was supported in part by the National Council on Science and Technology (26206-M, 38911-M), in Mexico, and the Division of Intramural Research, National Institutes of Health, U.S. Department of Health and Human Services (ZO1 ES 49019, ES 25045). The National Institute of Mental Health supported Dr Laird.
- Mudway IS, Kelly FJ: Ozone and the lung: a sensitive issue. Mol Aspects Med 2000, 21:1–48.PubMedView Article
- Brown JS: Acute effects of exposure to ozone in humans: How low can levels be and still produce effects? Am J Respir Crit Care Med 2009,180(3):200–201.PubMedView Article
- Bowler RP, Crapo JD: Oxidative Stress in allergic respiratory diseases. J Allergy Clin Immunol 2002, 110:349–356.PubMedView Article
- Trenga CA, Koenig JQ, Williams PV: Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch Environ Health 2001, 56:242–249.PubMedView Article
- Keranis E, Makris D, Rodopoulou P, Martinou H, Papamakarios G, Daniil Z, Zintzaras E, Giurgoulianis KI: Impact of dietary shift to higher antioxidant foods in COPD: a randomized trial. Eur Respir J 2010,36(4):774–80.PubMedView Article
- Goodrich GG, Goodman PH, Buhecha SK, Pritsos CA: Functional polymorphism of detoxification gene NQO1 predicts intensity of empirical treatment of childhood asthma. Mutat Res 2009, 674:55–61.PubMedView Article
- Reddy P, Naidoo RN, Robins TG, Mentz G, London SJ, Li H, Naidoo R: GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren. Lung 2010, 188:409–414.PubMedView Article
- Riedl MA, Nel AE: Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008, 8:49–56.PubMedView Article
- Romieu I, Sienra-Monge JJ, Ramírez-Aguilar M, Moreno-Macías H, Reyes-Ruiz NI, Del Río-Navarro BE, Hernández-Avila M, London SJ: Genetic Polimorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 2004, 59:8–10.PubMed
- Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes NI, Del Rio BE, Ruiz X, Hatch G, Slade R, Hernández-Avila M: Antioxidants supplementation and lung function among asthmatic children exposed to high levels of air pollutants. Am J Resprit Crit Care Med 2002, 166:703–709.View Article
- Barraza-Villarreal A, Sunyer J, Hernandez-Cadena L, Escamilla-Nuñez C, Sienra-Monge JJ, Ramirez-Aguilar M, Cortez-Lugo M, Holguin F, Diaz-Sanchez D, Olin AC, Romieu I: Air pollution, airway inflammation and lung function in a cohort study of Mexico City schoolchildren. Environ Health Perspect 2008, 116:832–838.PubMedView Article
- American Thoracic Society: Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995, 152:1107–1136.
- Weinmann GG, Weidenbach-Gerbase M, Foster WM, Zacur H, Frank R: Evidence for ozone-induced small-airway dysfunction: lack of menstrual-cycle and gender effects. Am J Respir Crit Care Med 1995,152(3):988–96.PubMed
- Tager IB, Balmes J, Lurmann F, Nqo L, Alcorn S, Künzil N: Chronic exposure to ambient ozone and lung function in young adults. Epidemiology 2005,16(6):751–9.PubMedView Article
- Galizia A, Kinney PL: Long-term residence in areas of high ozone: associations with respiratory health in a nationwide sample of nonsmoking young adults [dsee comments]. Environ Health Perspect 1999, 107:675–9.PubMedView Article
- GINA (Global Initiative for Asthma): Global Initiative for Asthma (GINA). Workshop report, Global Stratey for Asthma Management and Prevention. 2010. http://www.ginasthma.org/Guidelineitem.asp?l1=2&l2=1&intId=60
- Willett WC: Nutritional Epidemiology. New York: Oxford University Press; 1998.View Article
- Willett W, Stampfer MJ: Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 1986, 124:17–27.PubMed
- David GL, Romieu I, Sienra-Monge JJ, Collins WJ, Ramirez-Aguilra M, del Rio-Navarro BE, Reyes-Ruiz NI, Morris RW, Marzec JM, London SJ: Nicotinamide adenine dinucleotide (phosphate) reduced: Quinone oxidoreductase and glutathione S-transferase M1 plymorphisms and childhood asthma. Am J Respir Crit Care Med 2003, 168:1199–1204.PubMedView Article
- Tang H, Peng J, Wang P, Risch NJ: Estimation of individual admixture: Analytical and study design considerations. Genet Epidemiol 2005, 28:289–301.PubMedView Article
- Hancock DB, Romieu I, Shi M, Sienra-Monge JJ, Wu H, Chiu GY, Li H, del Rio Navarro BE, Willis-Owen SA, Weiss ST, Raby BA, Gao H, Eng C, Chapela R, Burchard EG, Tang H, Sullivan PF, London SJ: Genome-wide association study implicates chromosome 9q21.31 as a susceptibility locus for asthma in Mexican children. PLoS Genet 2009,5(8):e1000623.PubMedView Article
- Lam TK, Ruczinski I, Helzlsouer K, Shugart Y, Li KE, Clipp S, Strickland PT, Alberg AJ: Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemil 2009, 19:546–552.View Article
- Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA: Human Glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frecuency distribution. Carcinogenesis 1998, 19:275–280.PubMedView Article
- Chen C, Arjomandi M, Tager IB, Holland N, Balmes JR: Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes. Eur Respir J 2007, 30:677–683.PubMedView Article
- Melén E, Nyberg F, Lindgren CM, Berglind N, Zucchelli M, Nordling E, Hallberg J, Svartengren M, Morgenstern R, Kere J, Bellander T, Wickman M, Pershagen G: Interactions between Glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Environ Health Perspect 2008, 116:1077–1084.PubMedView Article
- Tamer L, Calikoğlu M, Ates NA, Yildirim H, Ercan B, Saritas E, Unlü A, Atik U: Glutathione-s-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 2004, 9:493–498.PubMedView Article
- Islam T, Berhane K, McConnell R, Gauderman WJ, Avol E, Peters JM, Gilliland FD: Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax 2009, 64:197–202.PubMedView Article
- Lee YL, Lin YC, Lee YC, Wang JY, Hsiue TR, Guo YL: Glutathione Stransferase P1 gene polymorphism and air pollution as interactive risk factors for childhood asthma. Clin Exp Allergy 2004, 34:1707–1713.PubMedView Article
- Smit HA, Grreivink L, Tabak C: Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc Nutr Soc 1999, 58:197–202.View Article
- Secretaría del Medio Ambiente: Sistema Metropolitano Atmosférico (SIMAT). http://www.calidadaire.df.gob.mx/calidadaire/index.php?opcion=2&opcioninfopr%20oductos=26
- Rothman KJ, Greenland S: Modern Epidemiology. 2nd edition. Philadelphia: Lippincott Williams & Wilkins; 1998:257.
- Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, Moreno-Macias H, Rio-Navarro BE, David G, Marzec J, Hernandez-Avila M, London SJ: GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 2006, 28:953–959.PubMedView Article
- Ramírez-Aguilar M, Barraza-Villareal A, Moreno-Macías H, Winer AM, Cicero-Fernández P, Vélez-Márquez MG, Cortéz Lugo M, Sienra Monge JJ, Romieu I: Assessment of personal exposure to ozone in asthmatic children residing in Mexico City. Salud Publica Mex 2008, 50:67–75.PubMedView Article
- Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McInstosh A, Rosenfeld S: Comparative validation of the Block, Willett and National Cancer Institute Food Frequency Questionnaires. Am J Epidemiol 2001, 154:1089–99.PubMedView Article
- Smit HA: Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? Respir Res 2001, 2:261–264.PubMedView Article
- Kim JH, Ellwood PE, Asher MI: Diet and asthma: looking back, moving forward. Respir Res 2009, 10:49.PubMedView Article
- Polonikov AV, Ivanov VP, Solodilova MA, Panfilov VI: Tobacco smoking, fruit and vegetable intake modify association between -21A > T polymorphism catalase gene and risk of bronchial asthma. J Asthma 2009,46(3):217–24.PubMedView Article
- Romieu I, Barraza-Villarreal A, Escamilla-Núñez C, Texcalac-Sangrador JL, Hernández-Cadena L, Díaz-Sánchez D, De Battle J, Del Río-Navarro BE: Dietary intake, lung function and airway inflammation in Mexico City school children exposed to air pollutants. Respir Res 2009, 10:122.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.